December, 2008 (14)

• Fc receptors.
  Powell MS, Hogarth PM
  Adv Exp Med Biol. 2008 Dec; 640:22-34
• Citrullination of linear and cyclic altered peptide ligands from myelin basic protein (MBP(87-99)) epitope elicits a Th1 polarized response by T cells isolated from multiple sclerosis patients: implications in triggering disease.
  Deraos G, Chatzantoni K, Matsoukas MT, Tselios T, Deraos S, Katsara M, Papathanasopoulos P, Vynios D, Apostolopoulos V, Mouzaki A, Matsoukas J
  J Med Chem. 2008 Dec; 51(24):7834-7842
• Mechanisms of HIV non-progression; robust and sustained CD4+ T-cell proliferative responses to p24 antigen correlate with control of viraemia and lack of disease progression after long-term transfusion-acquired HIV-1 infection.
  Dyer WB, Zaunders JJ, Yuan FF, Wang B, Learmont JC, Geczy AF, Saksena NK, McPhee DA, Gorry PR, Sullivan JS
  Retrovirology. 2008 Dec; 5:112
• Using a surveillance system to identify and treat newly acquired hepatitis C infection.
  Walsh N, Lim M, Hellard M
  J Gastroenterol Hepatol. 2008 Dec; 23(12):1891-1894
• Investigation of pharmaceutical misuse amongst drug treatment clients.
  S. Nielson, B. Raimondo, Susan Carruthers, J. Fisher, N. Lintzeris, M. Stoové
  Turning Point Alcohol and Drug Centre. 2008 Dec; Final Report 2008
• Working with West African migrant communities on HIV prevention in Australia.
  Lemoh C, Biggs BA, Hellard M
  Sex Health. 2008 Dec; 5(4):313-314
• High incidence of hepatitis C virus reinfection in a cohort of injecting drug users.
  Aitken CK, Lewis J, Tracy SL, Spelman T, Bowden DS, Bharadwaj M, Drummer H, Hetlard M
  Hepatology. 2008 Dec; 48(6):1746-1752
• Individual and community correlates of young people's high-risk drinking in Victoria, Australia.
  Livingston M, Laslett AM, Dietze P
  Drug Alcohol Depend. 2008 Dec; 98(3):241-248
• Methadone- and buprenorphine-related ambulance attendances: a population-based indicator of adverse events.
  Nielsen S, Dietze P, Cantwell K, Lee N, Taylor D
  J Subst Abuse Treat. 2008 Dec; 35(4):457-461
• The good, the bad and the ugly: how altered peptide ligands modulate immunity.
  Katsara M, Minigo G, Plebanski M, Apostolopoulos V
  Expert Opin Biol Ther. 2008 Dec; 8(12):1873-1884
• Identification of a residue in hepatitis C virus E2 glycoprotein that determines scavenger receptor BI and CD81 receptor dependency and sensitivity to neutralizing antibodies.
  Grove J, Nielsen S, Zhong J, Bassendine MF, Drummer HE, Balfe P, McKeating JA
  J Virol. 2008 Dec; 82(24):12020-12029
• Spotlight on malaria: MAM2008.
  Cooke BM, Crabb BS, Cowman A
  Trends Parasitol. 2008 Dec; 24(12):531
• Deletion of the Plasmodium falciparum merozoite surface protein 7 gene impairs parasite invasion of erythrocytes.
  Kadekoppala M, O'Donnell RA, Grainger M, Crabb BS, Holder AA
  Eukaryot Cell. 2008 Dec; 7(12):2123-2132
• Chlamydia testing and notification in Australia: more money more tests - Commentary
  Goller JL, Stoové MA, Hellard M
  Sex Trans Dis. 2008 Dec; 84(7):569-569

November, 2008 (11)

• Emergence of extensive drug resistance during treatment for multidrug-resistant tuberculosis.
  Cox HS, Sibilia K, Feuerriegel S, Kalon S, Polonsky J, Khamraev AK, Rusch-Gerdes S, Mills C, Niemann S
  N Engl J Med. 2008 Nov; 359(22):2398-2400
• Impact of prior immunological exposure on vaccine delivery by Salmonella enterica serovar Typhimurium.
  Gahan ME, Webster DE, Wijburg OLC, Wesselingh SL, Strugnell RA
  Vaccine. 2008 Nov; 26(49):6212-6220
• Drinking by professional Australian Football League (AFL) players: prevalence and correlates of risk.
  Dietze PM, Fitzgerald JL, Jenkinson RA
  Med J Aust. 2008 Nov; 189(9):479-483
• Evaluating new CD4 enumeration technologies for resource-constrained countries.
  Stevens W, Gelman R, Glencross DK, Scott LE, Crowe SM, Spira T
  Nat Rev Microbiol. 2008 Nov; 6(11 Suppl):S29-S38
• The oral health of street-recruited injecting drug users: prevalence and correlates of problems.
  Laslett AM, Dietze P, Dwyer R
  Addiction. 2008 Nov; 103(11):1821-1825
• Cancer exploiting complement: a clue or an exception?
  Loveland BE, Cebon J
  Nat Immunol. 2008 Nov; 9(11):1205-1206
• Protease inhibitor therapy in resource-limited settings.
  Elliott JH, Pujari S
  Curr Opin HIV AIDS. 2008 Nov; 3(6):612-619
• MHC and MHC-like molecules - structural perspectives on the design of molecular vaccines.
  Apostolopoulos V, Yuriev E, Lazoura E, Yu MM, Ramsland PA
  Hum Vaccin. 2008 Nov; 4(6):400-409
• Risky sexual behaviour in context: qualitative results from an investigation into risk factors for seroconversion among gay men who test for HIV.
  Elam G, Macdonald N, Hickson FCI, Imrie J, Power R, McGarrigle CA, Fenton KA, Gilbart VL, Ward H, Evans BG
  Sex Transm Infect. 2008 Nov; 84(6):473-477
• NeuroAIDS in the Asia Pacific Region.
  Wright EJ, Nunn M, Joseph J, Robertson K, Lal L, Brew BJ
  J Neurovirol. 2008 Nov; 14(6):465-473
• Sustainability science: an integrated approach for health-programme planning.
  Gruen RL, Elliott JH, Nolan ML, Lawton PD, Parkhill A, McLaren CJ, Lavis JN
  Lancet. 2008 Nov; 372(9649):1579-1589

October, 2008 (8)

• XDR tuberculosis can be cured with aggressive treatment.
  Cox H, McDermid C
  Lancet. 2008 Oct; 372(9647):1363-1365
• Rational use of antiretroviral therapy in low-income and middle-income countries: optimizing regimen sequencing and switching.
  Elliott JH, Lynen L, Calmy A, De Luca A, Shafer RW, Zolfo M, Clotet B, Huffam S, Boucher CAB, Cooper DA, Schapiro JM
  AIDS. 2008 Oct; 22(16):2053-2067
• Targeting subcapsular antigens for prevention of Klebsiella pneumoniae infections.
  Clements A, Jenney AW, Farn JL, Brown LE, Deliyannis G, Hartland EL, Pearse MJ, Maloney MB, Wesselingh SL, Wijburg OL, Strugnell RA
  Vaccine. 2008 Oct; 26(44):5649-5653
• The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement.
  Caminschi I, Proietto AI, Ahmet F, Kitsoulis S, Teh JS, Lo JCY, Rizzitelli A, Wu L, Vremec D, van Dommelen SLH, Campbell IK, Maraskovsky E, Braley H, Davey GM, Mottram P, De Velde NV, Jensen K, Lew AM, Wright MD, Heath WR, Shortman K, Lahoud MH
  Blood. 2008 Oct; 112(8):3264-3273
• Comparative genomics of the neglected human malaria parasite Plasmodium vivax.
  Carlton JM, Adams JH, Silva JC, Bidwell SL, Lorenzi H, Caler E, Crabtree J, Angiuoli SV, Merino EF, Amedeo P, Cheng Q, Coulson RMR, Crabb BS, del Portillo HA, Essien K, Feldblyum TV, Fernandez-Becerra C, Gilson PR, Gueye AH, Guo X, Kang'a S, Kooij TWA, Korsinczky M, Meyer EVS, Nene V, Paulsen I, White O, Ralph SA, Ren QH, Sargeant TJ, Salzberg SL, Stoeckert CJ, Sullivan SA, Yamamoto MM, Hoffman SL, Wortman JR, Gardner MJ, Galinski MR, Barnwell JW, Fraser-Liggett CM
  Nature. 2008 Oct; 455(7214):757-763
• Gender, culture and harm: an exploratory study of female heroin users of Vietnamese ethnicity.
  Higgs P, Owada K, Hellard M, Power R, Maher L
  Cult Health Sex. 2008 Oct; 10(7):681-696
• Human dendritic cells pulsed with specific lipopeptides stimulate autologous antigen-specific T cells without the addition of exogenous maturation factors.
  Jones KL, Brown LE, Eriksson EMY, Ffrench RA, Latour PA, Loveland BE, Wall DM, Roberts SK, Jackson DC, Gowans EJ
  J Viral Hepat. 2008 Oct; 15(10):761-772
• Can we predict neuropathy risk before stavudine prescription in a resource-limited setting?
  Affandi JS, Price P, Imran D, Yunihastuti E, Djauzi S, Cherry CL
  AIDS Res Hum Retroviruses. 2008 Oct; 24(10):1281-1284

September, 2008 (15)

• Blood-stage Plasmodium infection induces CD8+ T lymphocytes to parasite-expressed antigens, largely regulated by CD8alpha+ dendritic cells.
  Lundie RJ, de Koning-Ward TF, Davey GM, Nie CQ, Hansen DS, Lau LS, Mintern JD, Belz GT, Schofield L, Carbone FR, Villadangos JA, Crabb BS, Heath WR
  Proc Natl Acad Sci U S A. 2008 Sep; 105(38):14509-14514
• Primary HIV-1 R5 isolates from end-stage disease display enhanced viral fitness in parallel with increased gp120 net charge.
  Repits J, Sterjovski J, Badia-Martinez D, Mild M, Gray L, Churchill MJ, Purcell DFJ, Karlsson A, Albert J, Fenyo EM, Achour A, Gorry PR, Jansson M
  Virology. 2008 Sep; 379(1):125-134
• A self-adjuvanting lipopeptide-based vaccine candidate for the treatment of hepatitis C virus infection.
  Chua BY, Eriksson EM, Brown LE, Zeng WG, Gowans EJ, Torresi J, Jackson DC
  Vaccine. 2008 Sep; 26(37):4866-4875
• Attitudes of men in an Australian male tolerance study towards microbicide use.
  Holmes WR, Maher L, Rosenthal SL
  Sex Health. 2008 Sep; 5(3):273-278
• Protein/peptide and DNA vaccine delivery by targeting C-type lectin receptors.
  Tang CK, Sheng KC, Apostolopoulos V, Pietersz GA
  Expert Rev Vaccines. 2008 Sep; 7(7):1005-1018
• Strategies used for MUC1 immunotherapy: preclinical studies.
  Tang CK, Apostolopoulos V
  Expert Rev Vaccines. 2008 Sep; 7(7):951-962
• Unravelling the complicated networks of integrin alpha(IIb)beta(3) signalling in platelets
  Harris KS, Jackson DE
  Curr Sig Transd Ther. 2008 Sep; 3(31):158-167
• Bradykinin stimulates endothelial cell fatty acid oxidation by CaMKK-dependent activation of AMPK.
  Mount PF, Lane N, Venkatesan S, Steinberg GR, Fraser SA, Kemp BE, Power DA
  Atherosclerosis. 2008 Sep; 200(1):28-36
• Registered post achieved a higher response rate than normal mail--a randomized controlled trial.
  Pedrana A, Hellard M, Giles M
  J Clin Epidemiol. 2008 Sep; 61(9):896-899
• Strategies used for MUC1 immunotherapy: human clinical studies.
  Tang CK, Katsara M, Apostolopoulos V
  Expert Rev Vaccines. 2008 Sep; 7(7):963-975
• Saints and sinners: training Papua New Guinean (PNG) Christian Clergy to respond to HIV and AIDS using a model of care.
  Benton KW
  J Relig Health. 2008 Sep; 47(3):314-325
• Vectorial entry and release of hepatitis A virus in polarized human hepatocytes.
  Snooks MJ, Bhat P, Mackenzie J, Counihan NA, Vaughan N, Anderson DA
  J Virol. 2008 Sep; 82(17):8733-8742
• Bioinformatic prediction programs underestimate the frequency of CXCR4 usage by R5X4 HIV type 1 in brain and other tissues.
  Mefford ME, Gorry PR, Kunstman K, Wolinsky SM, Gabuzda D
  AIDS Res Hum Retroviruses. 2008 Sep; 24(9):1215-1220
• Cancer vaccines: methods for inducing immunity.
  Apostolopoulos V, Weiner DB, Gong JL
  Expert Rev Vaccines. 2008 Sep; 7(7):861-862
• Fiber-modified recombinant adenoviral constructs encoding hepatitis C virus proteins induce potent HCV-specific T cell response.
  Thammanichanond D, Moneer S, Yotnda P, Aitken C, Earnest-Silveira L, Jackson D, Hellard M, McCluskey J, Torresi J, Bharadwaj M
  Clin Immunol. 2008 Sep; 128(3):329-339

August, 2008 (13)

• A double mutation of MBP(83-99) peptide induces IL-4 responses and antagonizes IFN-gamma responses.
  Katsara M, Yuriev E, Ramsland PA, Tselios T, Deraos G, Lourbopoulos A, Grigoriadis N, Matsoukas J, Apostolopoulos V
  J Neuroimmunol. 2008 Aug; 200(1-2):77-89
• Stigma, social reciprocity and exclusion of HIV/AIDS patients with illicit drug histories: a study of Thai nurses' attitudes.
  Chan KY, Stoové MA, Reidpath DD
  Harm Reduct J. 2008 Aug; 5:28
• The adjuvanticity of a mannosylated antigen reveals TLR4 functionality essential for subset specialization and functional maturation of mouse dendritic cells.
  Sheng KC, Kalkanidis M, Pouniotis DS, Wright MD, Pietersz GA, Apostolopoulos VA
  J Immunol. 2008 Aug; 181(4):2455-2464
• Variable uptake of recommended interventions to reduce mother-to-child transmission of HIV in Australia, 1982-2005.
  Giles ML, McDonald AM, Elliott EJ, Ziegler JB, Hellard ME, Lewin SR, Kaldor JM
  Med J Aust. 2008 Aug; 189(3):151-154
• Double-antigen enzyme-linked immunosorbent assay for detection of hepatitis E virus-specific antibodies in human or swine sera.
  Hu WP, Lu Y, Precioso NA, Chen HY, Howard T, Anderson D, Guan M
  Clin Vaccine Immunol. 2008 Aug; 15(8):1151-1157
• What more can we learn from the heroin drought?
  Dietze P
  Int J Drug Policy. 2008 Aug; 19(4):270-272
• Reply to 'Response to Milland et al.: Carbohydrate residues downstream of the terminal gal alpha(1 3)gal epitope modulate the specificity of xenoreactive antibodies'
  Milland J, Yuriev E, Xing PX, McKenzie IFC, Ramsland PA, Christiansen D, Sandrin MS
  Immunol Cell Biol. 2008 Aug; 86(8):633-634
• Mannosylation of mutated MBP83-99 peptides diverts immune responses from Th1 to Th2.
  Katsara M, Yuriev E, Ramsland PA, Deraos G, Tselios T, Matsoukas J, Apostolopoulos V
  Mol Immunol. 2008 Aug; 45(13):3661-3670
• What is 'sex' exactly? Using cognitive interviewing to improve the validity of sexual behaviour reporting among young people in rural Zimbabwe.
  Mavhu W, Langhaug L, Manyonga B, Power R, Cowan F
  Cult Health Sex. 2008 Aug; 10(6):563-572
• Pathogenesis and diagnosis of viral infections of the nervous system.
  Wright EJ, Brew BJ, Wesselingh SL
  Neurol Clin. 2008 Aug; 26(3):617-33
• Mortality among injecting drug users in Melbourne: a 16-year follow-up of the Victorian Injecting Cohort Study (VICS).
  Stoové MA, Dietze PM, Aitken CK, Jolley D
  Drug Alcohol Depend. 2008 Aug; 96(3):281-285
• A report on the effect of commencing enfuvirtide on peripheral neuropathy.
  Cherry CL, Duncan AJ, Mackie KF, Wesselingh SL, Brew BJ
  AIDS Res Hum Retroviruses. 2008 Aug; 24(8):1027-1030
• Physical activity uptake in patients with HIV: who does how much?
  Fillipas S, Bowtell-Harris CA, Oldmeadow LB, Cicuttini F, Holland AE, Cherry CL
  Int J STD AIDS. 2008 Aug; 19(8):514-518

July, 2008 (8)

• Oxidized and reduced mannan mediated MUC1 DNA immunization induce effective anti-tumor responses.
  Tang CK, Sheng KC, Pouniotis D, Esparon S, Son HY, Kim CW, Pietersz GA, Apostolopoulos V
  Vaccine. 2008 Jul; 26(31):3827-3834
• Design of novel cyclic altered peptide ligands of myelin basic protein MBP83-99 that modulate immune responses in SJL/J mice.
  Katsara M, Deraos G, Tselios T, Matsoukas J, Apostolopoulos V
  J Med Chem. 2008 Jul; 51(13):3971-3978
• Towards immunotherapeutic drugs and vaccines against multiple sclerosis.
  Katsara M, Matsoukas J, Deraos G, Apostolopoulos V
  Acta Biochim Biophys Sin (Shanghai). 2008 Jul; 40(7):636-642
• A cross-sectional survey of young people attending a music festival: associations between drug use and musical preference.
  Lim MS, Hellard ME, Hocking JS, Aitken CK
  Drug Alcohol Rev. 2008 Jul; 27(4):439-441
• Heterosubtypic T-cell responses against avian influenza H5 haemagglutinin are frequently detected in individuals vaccinated against or previously infected with human subtypes of influenza.
  Goy K, Von Bibra S, Lewis J, Laurie K, Barr I, Anderson D, Hellard M, Ffrench R
  Influenza Other Respi Viruses. 2008 Jul; 2(4):115-125
• Immune reconstitution disease of the central nervous system.
  Torok ME, Kambugu A, Wright E
  Curr Opin HIV AIDS. 2008 Jul; 3(4):438-445
• Efficacy trials of biomedical strategies to prevent HIV infection.
  Kaldor JM, Guy RJ, Wilson D
  Curr Opin HIV AIDS. 2008 Jul; 3(4):504-508
• Neurologic disorders are prevalent in HIV-positive outpatients in the Asia-Pacific region.
  Wright E, Brew B, Arayawichanont A, Robertson K, Samintharapanya K, Kongsaengdao S, Lim M, Vonthanak S, Lal L, Sarim C, Huffam S, Li P, Imran D, Lewis J, Lun WH, Kamarulzaman A, Tau G, Ali ST, Kishore K, Bain MP, Dwyer R, McCormack G, Hellard M, Cherry C, McArthur J, Wesselingh S
  Neurology. 2008 Jul; 71(1):50-56

June, 2008 (14)

• Patterns and incidence of gamma-hydroxybutyrate (GHB)-related ambulance attendances in Melbourne, Victoria.
  Dietze PM, Cvetkovski S, Barratt MJ, Clemens S
  Med J Aust. 2008 Jun; 188(12):709-711
• In utero model for pharmacologically investigating spontaneous activity during early ontogeny.
  Stockx EM, Cooke IRC, Berger PJ
  J Neurosci Methods. 2008 Jun; 171(1):53-59
• Risk behaviours and blood borne virus exposure for transient workers in rural Victoria.
  Pedrana A, Aitken C, Higgs P, Hellard M
  Aust J Rural Health. 2008 Jun; 16(3):143-149
• Antibody-ligand docking: insights into peptide-carbohydrate mimicry
  Yuriev E, Sandrin MS, Ramsland PA
  Mol Simul. 2008 Jun; 34(4):461-468
• Robust NK cell-mediated human immunodeficiency virus (HIV)-specific antibody-dependent responses in HIV-infected subjects.
  Stratov I, Chung A, Kent SJ
  J Virol. 2008 Jun; 82(11):5450-5459
• Antifungal prophylaxis in adult stem cell transplantation and haematological malignancy.
  Slavin MA, Heath CH, Thursky KA, Morrissey CO, Szer J, Ling LM, Milliken ST, Grigg AP
  Intern Med J. 2008 Jun; 38(6b):468-476
• Mechanisms of inhibition of HIV replication by non-nucleoside reverse transcriptase inhibitors.
  Sluis-Cremer N, Tachedjian G
  Virus Res. 2008 Jun; 134(1-2):147-156
• Enhanced case detection for newly acquired hepatitis C infection: epidemiological findings and health service implications.
  Guy R, Devadason D, Lim M, Higgins N, Pedrana A, Gibson K, Lewis J, Spelman T, White B, Kaldor J, Hellard M
  Commun Dis Intell. 2008 Jun; 32(2):250-256
• Diagnostic and therapeutic approach to persistent or recurrent fevers of unknown origin in adult stem cell transplantation and haematological malignancy.
  Morrissey CO, Bardy PG, Slavin MA, Ananda-Rajah MR, Chen SC, Kirsa SW, Ritchie DS, Upton A
  Intern Med J. 2008 Jun; 38(6b):477-495
• Prevalence of HSV-2 antibody in a Melbourne antenatal population attending a tertiary obstetric hospital.
  Sasadeusz JJ, Silvers JE, Kent HE, Devenish W, Hocking J, Garland SM
  Aust N Z J Obstet Gynaecol. 2008 Jun; 48(3):266-272
• Associations of substance abuse and sexual risks with self-reported depressive symptoms in young adults in northern Thailand.
  Celentano DD, Aramrattana A, Sutcliffe CG, Sirirojn B, Quan VM, Taechareonkul S, Sherman S, Sintupat K, Thomson N, Latkin C
  J Addict Med. 2008 Jun; 2(2):66-73
• Preventing invasive fungal infection during hospital building works.
  Chang CC, Athan E, Morrissey CO, Slavin MA
  Intern Med J. 2008 Jun; 38(6):538-541
• A very low response rate in an on-line survey of medical practitioners.
  Aitken C, Power R, Dwyer R
  Aust N Z J Public Health. 2008 Jun; 32(3):288-289
• Characteristics of HIV diagnoses in Australia, 1993-2006.
  Guy RJ, McDonald AM, Bartlett MJ, Murray JC, Giele CM, Davey TM, Appuhamy RD, Knibbs P, Coleman D, Hellard ME, Grulich AE, Kaldor JM
  Sex Health. 2008 Jun; 5(2):91-96

May, 2008 (7)

• Vaccination against foot-and-mouth disease virus using peptides conjugated to nano-beads.
  Greenwood DLV, Dynon K, Kalkanidis M, Xiang S, Plebanski M, Scheerlinck JPY
  Vaccine. 2008 May; 26(22):2706-2713
• Attitudes of Australian heroin users to peer distribution of naloxone for heroin overdose: perspectives on intranasal administration.
  Kerr D, Dietze P, Kelly AM, Jolley D
  J Urban Health. 2008 May; 85(3):352-360
• Dual infection with hepatitis A and E viruses in outbreaks and in sporadic clinical cases: Cuba 1998-2003.
  Rodríguez Lay Lde L, Quintana A, Villalba MC, Lemos G, Corredor MB, Moreno AG, Prieto PA, Guzmán MG, Anderson D
  J Med Virol. 2008 May; 80(5):798-802
• SMS STI: a review of the uses of mobile phone text messaging in sexual health.
  Lim MS, Hocking JS, Hellard ME, Aitken CK
  Int J STD AIDS. 2008 May; 19(5):287-290
• Reducing harmful traditional practices in Adjibar, Ethiopia: lessons learned from the Adjibar Safe Motherhood Project.
  Natoli L, Renzaho AMN, Rinaudo T
  Contemp Nurse. 2008 May; 29(1):110-119
• Kynurenine pathway metabolism in human blood-brain-barrier cells: implications for immune tolerance and neurotoxicity.
  Owe-Young R, Webster NL, Mukhtar M, Pomerantz RJ, Smythe G, Walker D, Armati PJ, Crowe SM, Brew BJ
  J Neurochem. 2008 May; 105(4):1346-1357
• Phase 1 single dose studies to optimize the pharmacokinetics of DG17, a novel HIV-protease inhibitor pro-drug, using sodium bicarbonate and ritonavir.
  Cherry CL, Hoy JF, Rowe JS, Krum H, Mills J, Lewin SR
  Curr HIV Res. 2008 May; 6(3):272-275

April, 2008 (6)

• Quantifying hepatitis C transmission risk using a new weighted scoring system for the Blood-Borne Virus Transmission Risk Assessment Questionnaire (BBV-TRAQ): applications for community-based HCV surveillance, education and prevention.
  Stoové MA, Fry CL, Lintzeris N
  Harm Reduct J. 2008 Apr; 5:12
• Investigation of a novel approach to scoring Giemsa-stained malaria-infected thin blood films.
  Proudfoot O, Drew N, Scholzen A, Xiang S, Plebanski M
  Malar J. 2008 Apr; 7:62
• The usefulness of twenty-four molecular markers in predicting treatment outcome with combination therapy of amodiaquine plus sulphadoxine-pyrimethamine against falciparum malaria in Papua New Guinea.
  Marfurt J, Mueller I, Sie A, Oa O, Reeder JC, Smith TA, Beck HP, Genton B
  Malar J. 2008 Apr; 7:61
• Using immunization delivery strategies to accelerate progress in Africa towards achieving the Millennium Development Goals.
  Clements CJ, Nshimirimanda D, Gasasira A
  Vaccine. 2008 Apr; 26(16):1926-1933
• Managing information: using systematic data collection to estimate process and impact indicators related to harm reduction services in Myanmar.
  Baldwin S, Boisen N, Power R
  Int J Drug Policy. 2008 Apr; 19 Suppl 1:S74-S79
• Consecutive infections and clearances of different hepatitis C virus genotypes in an injecting drug user.
  Aitken CK, Tracy SL, Revill P, Bharadwaj M, Bowden DS, Winter RJ, Hellard ME
  J Clin Virol. 2008 Apr; 41(4):293-296

March, 2008 (14)

• Evolution of DC-SIGN use revealed by fitness studies of R5 HIV-1 variants emerging during AIDS progression.
  Borggren M, Repits J, Kuylenstierna C, Sterjovski J, Churchill MJ, Purcell DFJ, Karlsson A, Albert J, Gorry PR, Jansson M
  Retrovirology. 2008 Mar; 5:28
• Primary T-lymphocytes rescue the replication of HIV-1 DIS RNA mutants in part by facilitating reverse transcription.
  Jones KL, Sonza S, Mak J
  Nucleic Acids Res. 2008 Mar; 36(5):1578-1588
• Intranasal naloxone for the treatment of suspected heroin overdose.
  Kerr D, Dietze P, Kelly AM
  Addiction. 2008 Mar; 103(3):379-386
• Virus-specific T-cell immunity correlates with control of GB virus B infection in marmosets.
  Woollard DJ, Haqshenas G, Dong XB, Pratt BF, Kent SJ, Gowans EJ
  J Virol. 2008 Mar; 82(6):3054-3060
• PECAM-1-regulated signalling thresholds control tolerance in anergic transgenic B-cells.
  Wong MX, Hayball JD, Jackson DE
  Mol Immunol. 2008 Mar; 45(6):1767-1781
• Impact of residues in the nonnucleoside reverse transcriptase inhibitor binding pocket on HIV-1 reverse transcriptase heterodimer stability.
  Figueiredo A, Zelina S, Sluis-Cremer N, Tachedjian G
  Curr HIV Res. 2008 Mar; 6(2):130-137
• The development of peer educator-based harm reduction programmes in Northern Vietnam.
  Walsh N, Gibbie TM, Higgs P
  Drug Alcohol Rev. 2008 Mar; 27(2):200-203
• Buprenorphine injection in Melbourne, Australia - an update.
  Aitken CK, Higgs PG, Hellard ME
  Drug Alcohol Rev. 2008 Mar; 27(2):197-199
• Barriers to the delivery of the hepatitis B birth dose: a study of five Papua New Guinean hospitals in 2007.
  Downing SG, Lagani W, Guy R, Hellard M
  P N G Med J. 2008 Mar; 51(1-2):47-55
• Long term efficacy of DOTS regimens for tuberculosis: systematic review.
  Cox HS, Morrow M, Deutschmann PW
  BMJ. 2008 Mar; 336(7642):484-487
• Array-based gene discovery with three unrelated subjects shows SCARB2/LIMP-2 deficiency causes myoclonus epilepsy and glomerulosclerosis.
  Berkovic SF, Dibbens LM, Oshlack A, Silver JD, Katerelos M, Vears DF, Lüllmann-Rauch R, Blanz J, Zhang KW, Stankovich J, Kalnins RM, Dowling JP, Andermann E, Andermann F, Faldini E, D'Hooge R, Vadlamudi L, Macdonell RA, Hodgson BL, Bayly MA, Savige J, Mulley JC, Smyth GK, Power DA, Saftig P, Bahlo M
  Am J Hum Genet. 2008 Mar; 82(3):673-684
• Response to Birbeck et al. Lack of appropriate treatment for people with comorbid HIV/AIDS and epilepsy in sub-Saharan Africa. [Epilepsia. 2007]
  Wright E, Brew BJ, Lal L, Ali ST, Arayawichanont A, Imran D, Kamarulzaman A, Kongsaengdao S, Kruy L, Merati TP, Samintharapanya K, Sarim C, Tau G, Thangsing C, Vin-Samnang C, Wesselingh SL
  Epilepsia. 2008 Mar; 49(3):541-543
• Health perceptions of home-grown tobacco (chop-chop) smokers.
  Aitken C, Fry TR, Grahlmann L, Masters T
  Nicotine Tob Res. 2008 Mar; 10(3):413-416
• Differences in the social networks of ethnic Vietnamese and non-Vietnamese injecting drug users and their implications for blood-borne virus transmission.
  Aitken CK, Higgs P, Bowden S
  Epidemiol Infect. 2008 Mar; 136(3):410-416

February, 2008 (11)

• The acceptability and feasibility of peer worker support role in community based HCV treatment for injecting drug users.
  Norman J, Walsh NM, Mugavin J, Stoové MA, Kelsall J, Austin K, Lintzeris N
  Harm Reduct J. 2008 Feb; 5:8
• Autoantibody-catalyzed hydrolysis of amyloid beta peptide.
  Taguchi H, Planque S, Nishiyama Y, Symersky J, Boivin S, Szabo P, Friedland RP, Ramsland PA, Edmundson AB, Weksler ME, Paul S
  J Biol Chem. 2008 Feb; 283(8):4714-4722
• HIV-1 infection induces changes in expression of cellular splicing factors that regulate alternative viral splicing and virus production in macrophages.
  Dowling D, Nasr-Esfahani S, Tan CH, O'Brien K, Howard JL, Jans DA, Purcell DFJ, Stoltzfus CM, Sonza S
  Retrovirology. 2008 Feb; 5:18
• Transitions to injecting and risk of hepatitis C transmission among ethnic Vietnamese heroin smokers in Melbourne Australia
  Higgs P, Kelsall J, Nguyen QC
  Hepatitis Monthly. 2008 Feb; 8(2):115-120
• The rise of infectious syphilis in Victoria and the impact of enhanced clinical testing.
  Allen K, Guy R, Leslie D, Goller J, Medland N, Roth N, Lewis J, Hellard M
  Aust N Z J Public Health. 2008 Feb; 32(1):38-42
• Delivery of antigen using a novel mannosylated dendrimer potentiates immunogenicity in vitro and in vivo.
  Sheng KC, Kalkanidis M, Pouniotis DS, Esparon S, Tang CK, Apostolopoulos V, Pietersz GA
  Eur J Immunol. 2008 Feb; 38(2):424-436
• Selling syringes to injecting drug users: a study of five pharmacies in Hanoi, Vietnam.
  Pankonin CA, Higgs P, Reid G, Aitken C
  J Infect Dev Ctries. 2008 Feb; 2(1):51-58
• Amiloride derivatives inhibit coxsackievirus B3 RNA replication.
  Harrison DN, Gazina EV, Purcell DF, Anderson DA, Petrou S
  J Virol. 2008 Feb; 82(3):1465-1473
• Harm reduction ethics: Acknowledging the values and beliefs behind our actions.
  Fry CL, Khoshnood K, Power R, Sharma M
  Int J Drug Policy. 2008 Feb; 19(1):1-3
• Integrating enhanced hepatitis C testing and counselling in research.
  Winter R, Nguyen O, Higgs P, Armstrong S, Duong D, Thach ML, Aitken C, Hellard M
  Int J Drug Policy. 2008 Feb; 19(1):66-70
• Cytokine genotype suggests a role for inflammation in nucleoside analog-associated sensory neuropathy (NRTI-SN) and predicts an individual's NRTI-SN risk.
  Cherry CL, Rosenow A, Affandi JS, McArthur JC, Wesselingh SL, Price P
  AIDS Res Hum Retroviruses. 2008 Feb; 24(2):117-123

January, 2008 (14)

• Vaccination with in vitro grown whole tumor cells induces strong immune responses and retards tumor growth in a murine model of colorectal liver metastases.
  Fifis T, Lam I, Lin D, Malcontenti-Wilson C, Christophi C, Loveland B
  Vaccine. 2008 Jan; 26(2):241-249
• Immunogenicity of Plasmodium yoelii merozoite surface protein 4/5 produced in transgenic plants.
  Wang L, Webster DE, Campbell AE, Dry IB, Wesselingh SL, Coppel RL
  Int J Parasitol. 2008 Jan; 38(1):103-110
• Natural regulatory T cells and persistent viral infection.
  Li S, Gowans EJ, Chougnet C, Plebanski M, Dittmer U
  J Virol. 2008 Jan; 82(1):21-30
• Harm reduction programmes in the Asia--Pacific Region.
  Reid G, Devaney ML, Baldwin S
  Drug Alcohol Rev. 2008 Jan; 27(1):95-98
• An FcgammaRIIa-binding peptide that mimics the interaction between FcgammaRIIa and IgG.
  Cendron AC, Wines BD, Brownlee RT, Ramsland PA, Pietersz GA, Hogarth PM
  Mol Immunol. 2008 Jan; 45(2):307-319
• Dual ITAM-mediated proteolytic pathways for irreversible inactivation of platelet receptors: de-ITAM-izing FcgammaRIIa.
  Gardiner EE, Karunakaran D, Arthur JF, Mu FT, Powell MS, Baker RI, Hogarth PM, Kahn ML, Andrews RK, Berndt MC
  Blood. 2008 Jan; 111(1):165-174
• MHC and MHC-like molecules: structural perspectives on the design of molecular vaccines.
  Apostolopoulos V, Lazoura E, Yu MM
  Adv Exp Med Biol. 2008 Jan; 640:252-267
• Challenges in providing drug user treatment services in Russia: providers' views.
  Bobrova N, Rughnikov U, Neifeld E, Rhodes T, Alcorn R, Kirichenko S, Power R
  Subst Use Misuse. 2008 Jan; 43(12-13):1770-1784
• Enveloped viral fusion: insights into the fusion of hepatitis B viruses
  Chojnacki J, Grgacic EVL
  Fut Virol. 2008 Jan; 3(6):543-552
• Synthesis of succinimidoalkylbenzaldehyde analogues: Potential bifunctional linkers for bioconjugation
  Crosby IT, Pietersz GA, Ripper JA
  Aust J Chem. 2008 Jan; 61(2):138-143
• Cell-based influenza vaccines: progress to date.
  Audsley JM, Tannock GA
  Drugs. 2008 Jan; 68(11):1483-1491
• Syringe disposal bins: the outcomes of a free trial for city traders in an inner-city municipality Australia.
  Devaney M, Lynda Berends L
  Subst Use Misuse. 2008 Jan; 43(1):139-153
• Building capacity and community resilience to HIV: a project designed, implemented, and evaluated by young Lao people.
  Hoy D, Southavilay K, Chanlivong N, Phimphachanh C, Douangphachanh V, Toole MJ
  Glob Public Health. 2008 Jan; 3(1):47-61
• Stigmatization of AIDS patients: disentangling Thai nursing students' attitudes towards HIV/AIDS, drug use, and commercial sex.
  Chan KY, Stoové MA, Sringernyuang L, Reidpath DD
  AIDS Behav. 2008 Jan; 12(1):146-157